HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xianzhong Meng Selected Research

Atherosclerosis

1/2019MMP-12-Induced Pro-osteogenic Responses in Human Aortic Valve Interstitial Cells.
7/2015NOTCH1 regulates matrix gla protein and calcification gene networks in human valve endothelium.
11/2011Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells.
12/2010Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xianzhong Meng Research Topics

Disease

19Inflammation (Inflammations)
01/2022 - 08/2006
18Ischemia
01/2023 - 02/2002
15Neoplasms (Cancer)
08/2023 - 03/2010
13Adenocarcinoma
08/2023 - 03/2010
12Reperfusion Injury
01/2019 - 06/2008
10Spinal Cord Ischemia
01/2022 - 01/2011
8Endotoxemia
05/2023 - 01/2002
8Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 01/2008
7Aortic Valve Disease
01/2023 - 11/2012
7Lung Neoplasms (Lung Cancer)
10/2020 - 02/2012
7Myocardial Ischemia (Ischemic Heart Diseases)
03/2016 - 02/2002
6Hyperplasia
10/2022 - 08/2002
6Hemorrhagic Shock
11/2015 - 05/2002
4Sepsis (Septicemia)
01/2023 - 05/2002
4Infarction (Infarctions)
01/2022 - 12/2011
4Barrett Esophagus (Barrett's Esophagus)
01/2021 - 12/2009
4Adenocarcinoma of Lung
10/2020 - 02/2012
4Atherosclerosis
01/2019 - 12/2010
4Paraplegia (Spastic Paraplegia)
03/2015 - 01/2011
4Acute Lung Injury
06/2012 - 04/2003
3Spinal Cord Injuries (Spinal Cord Injury)
01/2023 - 01/2011
3Stroke (Strokes)
11/2020 - 05/2013
3Intervertebral Disc Displacement (Herniated Disc)
12/2019 - 04/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 09/2012
3Gastroesophageal Reflux (GERD)
03/2010 - 06/2008
2Osteoporosis
05/2023 - 04/2021
2Carcinogenesis
01/2022 - 06/2008
2Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 05/2011
2Neurologic Manifestations (Neurological Manifestations)
12/2019 - 01/2011
2Myocardial Infarction
01/2019 - 12/2011
2Metaplasia
01/2019 - 06/2008
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2018 - 03/2015
2Sclerosis
06/2017 - 01/2017
2Transfusion-Related Acute Lung Injury
01/2017 - 02/2009
2Infections
12/2015 - 03/2010
2Shock
11/2015 - 06/2012
2Vascular Calcification
11/2015 - 04/2011
2Neoplasm Metastasis (Metastasis)
09/2012 - 02/2012

Drug/Important Bio-Agent (IBA)

13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2011 - 02/2002
11Secretory Phospholipases A2IBA
01/2021 - 12/2009
10Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2008
8Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2023 - 08/2002
8Toll-Like Receptor 4IBA
01/2022 - 03/2005
8Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 01/2008
7Phospholipases (Phospholipase)IBA
04/2013 - 06/2008
6EnzymesIBA
11/2020 - 06/2008
5salicylhydroxamic acid (SHAM)IBA
01/2023 - 01/2011
5Simvastatin (Zocor)FDA LinkGeneric
10/2022 - 11/2011
5NF-kappa B (NF-kB)IBA
01/2021 - 02/2002
5ErythropoietinFDA Link
12/2018 - 01/2011
5CytokinesIBA
01/2017 - 08/2006
4Interleukin-6 (Interleukin 6)IBA
05/2023 - 03/2016
4InterleukinsIBA
01/2020 - 08/2006
4oxidized low density lipoproteinIBA
01/2017 - 04/2011
4Messenger RNA (mRNA)IBA
07/2015 - 02/2002
3GlypicansIBA
08/2023 - 10/2022
3Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
05/2023 - 08/2002
3Diazoxide (Hyperstat)FDA Link
01/2023 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2023 - 12/2012
3Nicorandil (SG 75)IBA
01/2023 - 01/2021
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2022 - 11/2011
3Phosphotransferases (Kinase)IBA
01/2021 - 03/2015
3Oxygen (Dioxygen)IBA
05/2015 - 08/2007
3BiglycanIBA
04/2015 - 11/2012
2ElementsIBA
05/2023 - 04/2021
2Toll-Like Receptor 2IBA
01/2023 - 10/2020
2Adenosine Triphosphate (ATP)IBA
01/2023 - 01/2021
2Potassium Channels (Potassium Channel)IBA
01/2023 - 01/2021
2Deoxycholic Acid (Sodium Deoxycholate)IBA
01/2022 - 01/2022
2CollagenIBA
01/2022 - 06/2017
2CalciumIBA
12/2021 - 07/2008
2SolutionsIBA
01/2021 - 01/2021
2Atorvastatin (Lipitor)FDA Link
01/2021 - 11/2011
2ErbB Receptors (EGF Receptor)IBA
01/2021 - 12/2012
2Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2020 - 03/2015
2Nerve Growth Factors (Neurotrophins)IBA
11/2020 - 03/2015
2Matrilin ProteinsIBA
01/2020 - 01/2017
2Neuroprotective AgentsIBA
12/2018 - 01/2018
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2015 - 09/2014
2EicosanoidsIBA
08/2014 - 06/2012
2Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2014 - 05/2002
2Eosine Yellowish-(YS) (Eosin)IBA
11/2012 - 06/2008
2Group II Phospholipases A2IBA
11/2012 - 09/2012
2Hematoxylin (Haematoxylon)IBA
11/2012 - 06/2008
2AcidsIBA
05/2011 - 04/2010
2Interleukin-1beta (Interleukin 1 beta)IBA
02/2011 - 08/2002
2Hemoglobins (Hemoglobin)IBA
04/2009 - 08/2007
2Peptides (Polypeptides)IBA
05/2008 - 02/2002
2NF-KappaB Inhibitor alphaIBA
02/2003 - 02/2002
1Fluorouracil (Carac)FDA LinkGeneric
08/2023
12- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA
01/2023
12- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
01/2023

Therapy/Procedure

8Therapeutics
08/2023 - 01/2011
3Injections
01/2021 - 12/2011
2Punctures
01/2023 - 06/2012
2Operative Surgical Procedures
02/2018 - 08/2016
2Diskectomy (Discectomy)
02/2018 - 04/2008
1Drug Therapy (Chemotherapy)
08/2023
1Neoadjuvant Therapy
08/2023
1Ligation
01/2023